Harm Sinnige
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 16
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 7
- Hematology 13
- Multiple Myeloma Research and Treatments 8
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Linda Mol (5 shared papers)Miriam Koopman (5 shared papers)Cornelis J.A. Punt (4 shared papers)Ninja Antonini (3 shared papers)Otilia Dalesio (2 shared papers)Frans Erdkamp (2 shared papers)C. J. Rodenburg (2 shared papers)Annemieke Cats (1 shared paper)
- Journals
- Blood (5 papers)Annals of Hematology (3 papers)European Journal of Cancer (2 papers)Haematologica (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Harm Sinnige
27 papers receiving 2.1k citations
Harm Sinnige's Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 1.3k
- Hematology 430
- Hepatology 274
- Pathology and Forensic Medicine 246
- Cancer Research 166
Countries citing papers authored by Harm Sinnige
This map shows the geographic impact of Harm Sinnige's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harm Sinnige with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harm Sinnige more than expected).
Fields of papers citing papers by Harm Sinnige
This network shows the impact of papers produced by Harm Sinnige. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harm Sinnige. The network helps show where Harm Sinnige may publish in the future.
Co-authors
The 25 scholars most cited alongside Harm Sinnige, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer Hit paper breakdown → | 2009 | 1004 |
| 2 | 2007 | 461 | |
| 3 | 2010 | 190 | |
| 4 | 2011 | 125 | |
| 5 | 2019 | 119 | |
| 6 | 2004 | 49 | |
| 7 | 2008 | 35 | |
| 8 | 2011 | 30 | |
| 9 | 2003 | 25 | |
| 10 | 2007 | 24 | |
| 11 | 2010 | 11 | |
| 12 | 2008 | 10 | |
| 13 | 1993 | 9 | |
| 14 | 2017 | 8 | |
| 15 | 2012 | 8 | |
| 16 | 2016 | 7 | |
| 17 | 2013 | 6 | |
| 18 | Colorectal carcinoma: an update. | 1991 | 6 |
| 19 | 1992 | 5 | |
| 20 | 1990 | 5 |
About Harm Sinnige
Harm Sinnige is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 29 papers that have together received 2.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Multiple Myeloma Research and Treatments (8 papers), Cancer Treatment and Pharmacology (7 papers), Acute Lymphoblastic Leukemia research (4 papers), Gastric Cancer Management and Outcomes (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer therapeutics and mechanisms (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Oncology (1.3k citations), Hematology (430 citations), Hepatology (274 citations), Pathology and Forensic Medicine (246 citations) and Cancer Research (166 citations). Harm Sinnige has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Linda Mol, Miriam Koopman, Cornelis J.A. Punt, Ninja Antonini, Otilia Dalesio, Frans Erdkamp, C. J. Rodenburg, Annemieke Cats, Emile E. Voest and D. J. Richel. Their work appears in journals such as Blood, Annals of Hematology, European Journal of Cancer, Haematologica and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.